160 related articles for article (PubMed ID: 10029443)
1. Alveolar adenoma: a histochemical, immunohistochemical, and ultrastructural analysis of 17 cases.
Burke LM; Rush WI; Khoor A; Mackay B; Oliveira P; Whitsett JA; Singh G; Turnicky R; Fleming MV; Koss MN; Travis WD
Hum Pathol; 1999 Feb; 30(2):158-67. PubMed ID: 10029443
[TBL] [Abstract][Full Text] [Related]
2. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium.
Devouassoux-Shisheboran M; Hayashi T; Linnoila RI; Koss MN; Travis WD
Am J Surg Pathol; 2000 Jul; 24(7):906-16. PubMed ID: 10895813
[TBL] [Abstract][Full Text] [Related]
3. Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung.
Zhou L; Lim L; Costa RH; Whitsett JA
J Histochem Cytochem; 1996 Oct; 44(10):1183-93. PubMed ID: 8813084
[TBL] [Abstract][Full Text] [Related]
4. [Alveolar adenoma of the lung. Immunohistochemical characterization of type II pneumocytes].
Köppl H; Freudenberg N; Berwanger I; Frenzer K; Böhm N
Pathologe; 1996 Mar; 17(2):150-3. PubMed ID: 8650145
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis.
Chan AC; Chan JK
Am J Surg Pathol; 2000 Nov; 24(11):1531-6. PubMed ID: 11075855
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis.
Hicks SM; Vassallo JD; Dieter MZ; Lewis CL; Whiteley LO; Fix AS; Lehman-McKeeman LD
Toxicology; 2003 May; 187(2-3):217-28. PubMed ID: 12699910
[TBL] [Abstract][Full Text] [Related]
7. Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans.
Kurotani R; Kumaki N; Naizhen X; Ward JM; Linnoila RI; Kimura S
Lung Cancer; 2011 Jan; 71(1):42-8. PubMed ID: 20466451
[TBL] [Abstract][Full Text] [Related]
8. FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo.
Clark JC; Tichelaar JW; Wert SE; Itoh N; Perl AK; Stahlman MT; Whitsett JA
Am J Physiol Lung Cell Mol Physiol; 2001 Apr; 280(4):L705-15. PubMed ID: 11238011
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal stromal tumors with prominent myxoid matrix. Clinicopathologic, immunohistochemical, and ultrastructural study of nine cases of a distinctive morphologic variant of myogenic stromal tumor.
Suster S; Sorace D; Moran CA
Am J Surg Pathol; 1995 Jan; 19(1):59-70. PubMed ID: 7802139
[TBL] [Abstract][Full Text] [Related]
10. Alveolar adenoma of the lung. Immunohistochemical and flow cytometric characteristics of two new cases and a review of the literature.
Sak SD; Koseoglu RD; Demirag F; Akbulut H; Gungor A
APMIS; 2007 Dec; 115(12):1443-9. PubMed ID: 18184418
[TBL] [Abstract][Full Text] [Related]
11. Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies.
Kitamura H; Kameda Y; Ito T; Hayashi H; Nakamura N; Nakatani Y; Inayama Y; Kanisawa M
Virchows Arch; 1997 Dec; 431(6):415-24. PubMed ID: 9428929
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative study of thyroid transcription factor-1 protein expression in lung carcinoma cell nucleus by tissue microarray].
Bai XY; Shen H
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1423-6. PubMed ID: 17062341
[TBL] [Abstract][Full Text] [Related]
13. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
14. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma.
Wang E; Lin D; Wang Y; Wu G; Yuan X
Hum Pathol; 2004 Apr; 35(4):503-8. PubMed ID: 15116333
[TBL] [Abstract][Full Text] [Related]
16. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
[TBL] [Abstract][Full Text] [Related]
17. Adenoma of type 2 pneumocytes with oncocytic features.
Fine G; Chang CH
Arch Pathol Lab Med; 1991 Aug; 115(8):797-801. PubMed ID: 1863190
[TBL] [Abstract][Full Text] [Related]
18. Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization.
Broers JL; Jensen SM; Travis WD; Pass H; Whitsett JA; Singh G; Katyal SL; Gazdar AF; Minna JD; Linnoila RI
Lab Invest; 1992 Mar; 66(3):337-46. PubMed ID: 1311398
[TBL] [Abstract][Full Text] [Related]
19. Papillary adenoma of type II pneumocytes might have malignant potential.
Mori M; Chiba R; Tezuka F; Kaji M; Kobubo T; Nukiwa T; Takahashi T
Virchows Arch; 1996 Jun; 428(3):195-200. PubMed ID: 8688974
[TBL] [Abstract][Full Text] [Related]
20. Type-II pneumocyte differentiation in pulmonary sclerosing hemangioma: ultrastructural differentiation and immunohistochemical distribution of lineage-specific transcription factors (TTF-1, HNF-3 alpha, and HNF-3 beta) and surfactant proteins.
Yamazaki K
Virchows Arch; 2004 Jul; 445(1):45-53. PubMed ID: 15138814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
